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Edited by Irmgard SinningAbstract The crystal structure of b-hydroxyacyl acyl carrier
protein dehydratase of Plasmodium falciparum (PfFabZ) has
been determined at a resolution of 2.4 A˚. PfFabZ has been found
to exist as a homodimer (d-PfFabZ) in the crystals of the present
study in contrast to the reported hexameric form (h-PfFabZ)
which is a trimer of dimers crystallized in a diﬀerent condition.
The catalytic sites of this enzyme are located in deep narrow tun-
nel-shaped pockets formed at the dimer interface. A histidine res-
idue from one subunit of the dimer and a glutamate residue from
the other subunit lining the tunnel form the catalytic dyad in the
reported crystal structures. While the position of glutamate re-
mains unaltered in the crystal structure of d-PfFabZ compared
to that in h-PfFabZ, the histidine residue takes up an entirely
diﬀerent conformation and moves away from the tunnel leading
to a His-Phe cis–trans peptide ﬂip at the histidine residue. In
addition, a loop in the vicinity has been observed to undergo a
similar ﬂip at a Tyr–Pro peptide bond. These alterations not only
prevent the formation of a hexamer but also distort the active
site geometry resulting in a dimeric form of FabZ that is incapa-
ble of substrate binding. The dimeric state and an altered cata-
lytic site architecture make d-PfFabZ distinctly diﬀerent from
the FabZ structures described so far. Dynamic light scattering
and size exclusion chromatographic studies clearly indicate a
pH-related switching of the dimers to active hexamers.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Enzymes involved in fatty acid biosynthesis of the malaria
parasite, Plasmodium falciparum, are attractive targets for theAbbreviations: FabZ, b-hydroxyacyl ACP dehydratase; PfFabZ, FabZ
from Plasmodium falciparum; d-PfFabZ, dimeric form of FabZ from
Plasmodium falciparum; h-PfFabZ, hexameric form of FabZ from
Plasmodium falciparum; PaFabZ, FabZ from Pseudomonas Aerugin-
osa; ACP, acyl carrier protein; FabA, b-hydroxydecanoyl ACP dehy-
dratase; EcFabA, FabA from Escherichia coli; DLS, dynamic light
scattering; RH, hydrodynamic radius
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asite and the host are markedly diﬀerent [1–8]. In the type I or
the associative pathway, present in the humans, a single multi-
domain protein is involved in carrying out the various steps re-
quired for the elongation of the fatty acid chain, whereas in the
type II or the dissociative pathway of plants, bacteria and cer-
tain protozoans, each reaction is catalyzed by a distinct en-
zyme and the intermediates are shuttled from one enzyme to
another by a small protein – the acyl carrier protein (ACP)
[9]. b-Hydroxyacyl ACP dehydratase (FabZ) catalyzes the
third step in fatty acid elongation, i.e., the dehydration of
b-hydroxyacyl ACP to trans-2-enoyl-ACP [10–12]. In gram-
negative bacteria, a bifunctional enzyme FabA (b-hydroxy-
decanoyl dehydratase), an isoform of FabZ, also exists which
carries out an additional isomerization reaction by converting
trans-2-enoyl-ACP to cis-3-enoyl-ACP [10–12]. Crystal struc-
tures of FabA of Escherichia coli (EcFabA) [13], FabZ of Pseu-
domonas aeruginosa (PaFabZ) [14] and hexameric FabZ of P.
falciparum (h-PfFabZ) [15] revealed the ‘hot-dog’ fold of the
enzyme and active site tunnels formed between two subunits
that accommodate hydrocarbon chains of the fatty acids to
carry out the catalytic reactions by two catalytic residues, his-
tidine and glutamate, each from a diﬀerent subunit. EcFabA is
a dimeric enzyme, whereas PaFabZ and h-PfFabZ are hexa-
mers formed by three dimers. The dimers being symmetric,
two active sites are formed at each dimer interface. FabA is
highly eﬃcient if the substrate consists of saturated acyl chain
of shorter than 10 carbon atoms, whereas FabZ acts on longer
saturated and unsaturated hydrocarbon chains [10,16–18]. A
comparison of these structures showed that the shape of the
tunnel in EcFabA is slightly diﬀerent from that of PaFabZ
[14] and h-PfFabZ [15] enabling it to perform isomerization
activity [19].
Investigations of the type II fatty acid biosynthesis were
initiated in our laboratory with the demonstration of the
presence of this pathway in the malaria parasite, P. falcipa-
rum, and its inhibition by triclosan [4–6]. Further studies in-
clude identiﬁcation and biochemical characterization [20–22]
and structural studies [23,24] on the enzymes involved in
the pathway. We have characterized FabZ of the parasite
and also identiﬁed two potential inhibitors for the enzyme
by modeling studies [20]. We now present the crystal struc-
ture of d-PfFabZ, a dimeric form of the enzyme, at 2.4 A˚
which has revealed unique features of its catalytic site geom-
etry and oligomeric state and its comparison with the known
FabZ structures.blished by Elsevier B.V. All rights reserved.
Table 1
Data collection and reﬁnement statistics
Data collection
Unit cell parameters (A˚)
a 71.54
b 82.58
c 96.47
Space group I222
Resolution range (A˚) 31.0–2.4 (2.53–2.40)
Temperature (K) 100
No. of subunits per asymmetric unit 2
No. of observed reﬂections 71895 (10255)
No. of unique reﬂections 11456 (1641)
Multiplicity 6.3 (6.2)
I/r(I) 20.7 (4.1)
Completeness (%) 100.0 (100.0)
Rmerge (%) 7.5 (41.8)
Reﬁnement
No. of reﬂections used
Total 11435
Working set 10864
Test set 571
R-factor (%) 22.1 (28.6)
Rfree (%) 24.7 (30.6)
No. of atoms
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as a dimer in the crystal [25]. This result had conﬁrmed our
earlier observation that d-PfFabZ exists in the dimeric state
with a molecular weight of 34.2 kDa in solution as well [20].
However, the crystal structure of FabZ of P. aeruginosa was
found to be a hexamer [14] despite the fact that the residues
at the dimer–dimer interface are totally conserved between
PaFabZ and d-PfFabZ. After we completed the structure of
d-PfFabZ, a hexameric form of FabZ from P. falciparum (h-
PfFabZ) was reported [15] with close similarity to the structure
of PaFabZ. A comparison of the dimeric and hexameric struc-
tures clearly indicates the structural basis for the existence of
the two diﬀerent oligomeric states of the same enzyme. A dif-
ferent architecture of the catalytic site with two cis to trans
peptide ﬂips in d-PfFabZ compared to PaFabZ and h-PfFabZ
prevent it from hexamer formation. We explored the reasons
for these oligomeric shifts by dynamic light scattering (DLS)
and size exclusion chromatography experiments conducted in
various conditions and established that a pH-related transition
occurs between the inactive dimers and active hexamers of
PfFabZ. These analyses should help in the design of PfFabZ
inhibitors for treating malaria.
Protein atoms 2030
Solvent atoms 95
Average B factors (A˚2)
Protein atoms 41.83
Water 46.26
RMS deviation from ideal values
Bond length (A˚) 0.007
Bond angle () 1.7
Dihedral angles () 26.6
Residues in Ramachandran plot (%)
Most allowed region 85.1
Allowed region 13.6
Generously allowed region 1.4
Values in parentheses correspond to the highest resolution shell.2. Materials and methods
PfFabZ (mature) was cloned in pET-28a(+) as described earlier [20].
The puriﬁcation protocol is essentially the same as described in the ear-
lier work except that secondary culture was induced by 0.6 mM isopro-
pyl-1-thio-b-D-galactopyranoside (IPTG) and 10% glycerol was added
in all the buﬀers during puriﬁcation steps.
Puriﬁed PfFabZ has been crystallized in microbatch method (evap-
oration through silicone oil) by mixing 2 ll of 10–12 mg/ml of protein
with 2 ll of 30% PEG 4000 and 0.2 M ammonium acetate in 0.1 M
acetate buﬀer at pH 4.5. Crystals appeared in 2–3 days and grew to
the ﬁnal size of 0.45 · 0.15 · 0.05 mm in a week. A data set to a reso-
lution of 2.5 A˚ has already been reported [25]. However, a recently col-
lected data up to a resolution of 2.4 A˚ has better diﬀraction statistics
and is reported here. Diﬀraction data were collected at 100 K with
20% glycerol in crystallization condition as a cryoprotectant. Crystals
belong to the space group I222 with a dimer in the asymmetric unit.
Data were processed and merged using MOSFLM [26] and SCALA
[27]. Attempts to solve the structure of d-PfFabZ using the crystal
structure of EcFabA (PDB code: 1MKA) were not successful. The
structure was solved by molecular replacement using the program
PHASER [28] with the crystal structure of PaFabZ (PDB code:1U1Z)
as a search model. Reﬁnement was carried out using CNS [29] and
model was built by a visual inspection using the graphics program O
[30]. Calculation of composite omit maps [31,32] at various stages of
reﬁnement enabled to locate the loops that diﬀer in orientation from
the initial model (1U1Z). Several rounds of reﬁnement and model
building yielded in a ﬁnal R-factor of 22.1% and Rfree of 24.7% (Table
1). The structure has around 85.1% of the residues in the most fa-
voured region and 13.6% in the allowed region of Ramachandran
map calculated with the program PROCHECK [33]. Structural super-
position was done using ALIGN [34]. The interactions were calculated
using CONTACT from CCP4 package [27].
DLS investigations of PfFabZ were performed on a DYNAPRO
instrument using 20 ll of sample with a data collection time of 10 s.
Dynamics V6 software was used to calculate the hydrodynamic radius
of PfFabZ.
For gel ﬁltration experiments, 12 ml Sephadex G-100 (Sigma) beads
was manually packed in a 25 cm · 1 cm column. The molecular size of
PfFabZ at diﬀerent concentrations and diﬀerent conditions were deter-
mined by plotting their respective log Mol. wt. vs Ve/Vo in the standard
curve (Fig. 1) obtained using lysozyme (14 kDa), carbonic anhydrase
(29 kDa), BSA (66 kDa) and alcohol dehydrogenase (150 kDa). The
void volume of the column was estimated to be 4.5 ml.
Activity assay for PfFabZ was performed by the method reported
earlier [20].3. Results and discussion
3.1. Structure of PfFabZ
Molecular replacement result shows that one dimer of d-
PfFabZ made up of two subunits A and B (Fig. 2a) forms
the asymmetric unit of the I222 cell of the crystal. Of the 144
residues (Ile87-Lys230) in each subunit of the mature enzyme,
133 residues between Lys94 and Ser229 of the A subunit and
134 residues between Asp91 and Ser229 of the B subunit are
visible in the electron density maps. Residues Gln164 to
Asn166 in subunit A and Asp161 to Asn165 in subunit B are
disordered and not visible in the electron density maps. They
belong to the loop connecting the central helix and ﬁrst b-
strand at the interface. This loop was disordered in PaFabZ
and h-PfFabZ as well.
As in the case of EcFabA, PaFabZ and h-PfFabZ (PDB
code: 1Z6B), each subunit of d-PfFabZ has a mixed a + b
‘hot-dog’ fold as shown in Fig. 2a. In each subunit, a central
long a-helix is surrounded by a six-stranded curved b-sheet.
The central a-helix (ac: Pro141-Asp161 which is the same as
a2 of h-PfFabZ) and the six b-strands (b1: Lys107-Gln112,
b2: Thr116-Gln122, b3: Phe169-Trp179, b4: Thr188-Lys199,
b5: Ile204-Val213 and b6: Lys216-Leu228) are exactly the
same as in h-PfFabZ. The N-terminal a-helix (Asp88-Leu96)
found in h-PfFabZ is not present in d-PfFabZ probably be-
cause the sequence of h-pfFabZ starts from Pro81 and that
Fig. 1. Calibration curve, for gel ﬁltration experiment, plotted against log molecular weight and Ve/Vo of the standard proteins used (a = alcohol
dehydrogenase, b = BSA, c = carbonic anhydrase, d = lysozyme). Elution volume (Ve) for a, b, c and d were 5400.0, 7560.0, 8820.0 and 10800.0 ll,
respectively.
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PfFabZ is shorter (Glu127-Asn131) in d-PfFabZ and is found
only in subunit B. The dimer is formed by the association of
b-sheets from both the subunits to form a continuous 12-
stranded anti-parallel b-sheet. The two central helices run anti-
parallel to each other at the dimer interface (Fig. 2b). The
dimerisation results in the formation of two active site tunnels.
A large surface area of 2200 A˚2 gets buried upon dimerisation.
3.2. The oligomeric state
The sequence of PfFabZ has 13% identity with that of EcF-
abA and 43% with that of PaFabZ. The dimeric association in
all the three enzymes is similar. EcFabA is a dimer whereas Pa-
FabZ and h-PfFabZ exist as hexamers. The rms deviations be-
tween d-PfFabZ and the three structures h-PfFabZ, PaFabZ
and EcFabA are 0.80, 1.29 and 2.13 A˚, respectively, when
the Ca positions of the dimers are superimposed using the pro-
gram ALIGN [34]. It was shown that FabZ of E. coli [35] and
Helicobacter pylori [36] also exist in hexameric state in solu-
tion. In distinct contrast, PfFabZ has a dimeric structure also,
as seen from the present analysis, which supports the earlier
solution studies [20]. A close examination has revealed that
the conformation of two loops involved in hexamer formation
are diﬀerent in FabZ structures in the two diﬀerent forms
(Fig. 2b). In both the loops, cis-peptides (Tyr100-Pro101 and
His133-Phe134 in PfFabZ numbering) were found in EcFabA,
PaFabZ and h-PfFabZ which, interestingly, become trans in d-
PfFabZ (Fig. 2c). One of the loops, loop A: Glu94 to Leu103,
is close to the N-terminus and the other loop, loop B: Ser124 to
Met140, contains the catalytic histidine residue, His133. These
two loops are not involved in crystal contacts either in d-
PfFabZ or in h-PfFabZ. Maximum deviations of 8.3 and
9.5 A˚ are observed at Tyr100 of loop A and Gly132 of loop
B when the structures of d-PfFabZ and h-PfFabZ are com-
pared. Loop B of d-PfFabZ prevents the formation of the
hexamers due to steric clashes wherein the favourable interac-tions made by loop A to form a hexamer are lost if it has a con-
formation as in d-PfFabZ. The most severe steric hindrance
occurs at the center of the hexamer between the side chains
of Phe134 of loop B due to the cis–trans conversion of the
His133-Phe134 peptide bond (Fig. 2d). Thus, apparently, the
present dimeric structure d-PfFabZ cannot form hexamers.
A dimeric form of PfFabZ was also mentioned along with
the crystal structure of h-PfFabz [15]. As details like the crys-
tallization condition and space group were not provided and
the two loops containing the cis peptide bonds were disor-
dered, we could not compare it with the structure reported
here.
3.3. The tunnel
As observed in EcFabA and PaFabZ, a well-formed tunnel
in the shape of a wormhole is present at the dimer interface
of PfFabZ to accommodate the substrate. As these enzymes
have homodimeric structure, two tunnels of the same nature
are present at each dimer interface. Both the subunits contrib-
ute to the formation of each tunnel. Each tunnel is formed by
residues from the central helix and the b-strand at the dimer
interface and loop A from one subunit; loop B and other small
regions from the other subunit (Fig. 3). In h-PfFabZ, loop A
lines the active site tunnel, with His98 pointing into the active
site. Loop B points into the active site placing the catalytic his-
tidine His133 in its active conformation (Fig. 3a) and also lines
the central hole of 4–6 A˚ diameter of the hexamer. In d-
PfFabZ, loop A moves into the tunnel ﬂipping His98 side
chain away from the tunnel (Fig. 3b). The next residue
Arg99 now protrudes into the tunnel. Whereas loop B moves
away from the catalytic site with His133 shifting 9.4 A˚ away
from its corresponding position in the hexamer. Phe169 from
the b-strand at the dimer interface has been observed to block
the inner end of the tunnel in ﬁve subunits of h-PfFabZ and is
not visible in the sixth one. In d-PfFabZ, residues at the begin-
ning of this b-strand also move by 3.0 A˚ taking the side chain
Fig. 2. (a) View of the dimer of PfFabZ showing the ‘hot-dog’ fold of the subunits. Subunit A is shown in blue and B in cyan. This ﬁgure and Fig. 3
are generated using PyMOL [37]. (b) Superposition of the dimer of d-PfFabZ (grey) and h-PfFabZ (wheat). The loops A and B that take up diﬀerent
conformations are highlighted: blue (d-PfFabZ) and pink (h-PfFabZ) in subunit A; cyan (d-PfFabZ) and orange (h-PfFabZ) in subunit B,
respectively. The 2-fold related loops of the dimer are not highlighted. (c) cis–trans ﬂips in the B subunit of d-PfFabZ. 2Fo  Fc density at 1.0r is
shown for d-PfFabZ. Colour code is as in Fig. 1b. (d) Comparison of h-PfFabZ (wheat) and superposition of three dimers of d-PfFabZ (grey) onto
the hexamer of h-PfFabZ to show the steric clashes involving loop B. Phe134 from three subunits is highlighted. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 3. The active site tunnel in (a) h-PfFabZ and in (b) d-PfFabZ. The
inhibitor 3-decynoyl-N-acetyl cysteamine from the crystal structure of
EcFabA (1MKA) is manually ﬁtted into the tunnel of h-PfFabZ and is
given as reference to show the diﬀerences in the shapes of the tunnel.
The surfaces that close the tunnel from the top are omitted for clarity.
The surfaces are generated using the PyMOL [37] plug-in of castP [38].
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80 A˚2) of this region in h-PfFabZ had already indicated its
inherent ﬂexibility. As a result of these rearrangements the
tunnel in d-PfFabZ has widened with respect to that of hexa-
meric structure (Fig. 3a and b). Large shifts in loops A and B
make the active site of d-PfFabZ completely diﬀerent from
that in h-PfFabZ.
3.4. The active site
In this class of enzymes, the two catalytic residues, a gluta-
mate from the N-terminal region of the central helix and a his-
tidine from loop B, located close to the tunnel entry are
contributed by diﬀerent subunits. The positions of the gluta-
mate residue (Glu147) are exactly the same in d-PfFabZ,h-PfFabZ and PaFabZ. The corresponding residue is an aspar-
tate in EcFabA, which is also located at the same position. In
h-PfFabZ, PaFabZ and EcFabA, histidine occupies a position
close to glutamate lining the tunnel, whereas the corresponding
histidine of d-PfFabZ, His133, takes up an entirely new posi-
tion away from the tunnel (Fig. 3). This is a surprising result
considering the other similarities among these enzymes and
the expectation of the two catalytic residues to be close to each
other. In h-PfFabZ, PaFabZ as well as in EcFabA, the peptide
bond between this histidine and the next residue, a phenylala-
nine, is in cis conformation while it changes to trans in d-
PfFabZ. Because of this ﬂip, the character of the catalytic site
is drastically changed. In this geometry, histidine is not capable
of taking part in catalysis unless a signiﬁcant conformational
change takes place when the substrate binds. The histidine is
known to be ﬂexible as its side chain was shown to ﬂip between
the active and inactive forms of FabA structures [13]. The side
chain of an arginine residue, Arg99 which is found to be inter-
acting with a sulphate ion in h-PfFabZ, now occupies the posi-
tion of the histidine side chain in d-PfFabZ. A histidine next to
Arg99, His98, is at a distance of 4.2 A˚ (as measured between
NE atoms of both the histidines) from the catalytic histidine
His133 in h-PfFabZ. His98 is the only charged residue, other
than the catalytic dyad, present in the tunnel. Loop A on
which His98 and Arg99 are located also undergoes a confor-
mational change moving into the tunnel with a cis–trans pep-
tide ﬂip at Tyr100-Pro101. The waters present at the
catalytic site are conserved including supposedly catalytic
water and a water bridge between the catalytic glutamate
and the catalytic histidine (arginine in the case of d-PfFabZ).
3.5. Solution studies to determine the conditions for the
oligomeric shifts
To investigate the conditions which govern the oligomeriza-
tion of the enzyme, DLS and size exclusion chromatography of
PfFabZ were carried out in various concentrations of the en-
zyme (2–14 mg/ml) at various pH values, in the absence and
in 5-fold molar excess of the substrate, crotonyl-CoA. At pH
7.5 at which the protein has been puriﬁed, PfFabZ is polydis-
perse (Fig. 4a). A number of states of the protein exist from
monomers to higher oligomers. With the addition of the sub-
strate, the population of hexamers increases signiﬁcantly with
a hydrodynamic radius (RH) of 5.1 nM and a molecular weight
corresponding to the hexamer (Fig. 4b). The major diﬀerence
in the crystallization of both the forms of PfFabZ was the
pH at which it was crystallized. To investigate the inﬂuence
of pH on the oligomeric state, DLS and gel ﬁltration studies
were carried out at the pH values of the crystallization condi-
tions of both the forms, 4.5 (d-PfFabZ) and 6.0 (h-PfFabZ)
using 0.1 M sodium acetate and sodium cacodylate buﬀers,
respectively. As observed from the previous crystallographic
and solution studies, PfFabZ has been found to be a dimer
with an RH of 3.9 nM at lower pH (4.5) (Fig. 4c) and a hexa-
mer at higher pH (6.0) (Fig. 4d). In the crystal structure of h-
PfFabZ, a cacodylate ion was bound at the active site. It is
clear that when crotonoyl-CoA or cacodylate is bound at the
active site PfFabZ is a hexamer. To examine whether the hex-
amer formation is due to the cacodylate or the pH, the exper-
iment was repeated at pH 6.0 using 0.1 MMES buﬀer. PfFabZ
was found to be a hexamer in MES buﬀer as well at pH 6.0 but
it required a minimum incubation time of eight hours for the
equilibrium to shift to a hexamer, whereas in the presence of
Fig. 4. DLS results of PfFabZ showing the plot of % intensity vs. hydrodynamic radius. PfFabZ (a) in Tris–NaCl buﬀer, pH 7.5 (b) with substrate
crotonoyl-CoA at pH 7.5 (c) in sodium acetate buﬀer at pH 4.5 (d) in sodium cacodylate buﬀer at pH 6.0 (e) with substrate crotonoyl-CoA at pH
4.5.
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with an incubation time of less than an hour. The dimeric
structure at pH 4.5 is unaﬀected by the substrate (Fig. 4e),
strongly indicating that the dimeric form is inactive which
was again veriﬁed by activity assay. Results obtained fromDLS studies in the presence and absence of glycerol are exactly
identical. The interconvertibility of dimeric and hexameric
states was conﬁrmed through DLS experiments by changing
the pH of the same solution. Gel ﬁltration results are in agree-
ment with DLS results indicating a molecular weight of
P.L. Swarnamukhi et al. / FEBS Letters 580 (2006) 2653–2660 2659around 34 kDa for the dimer and around 95 kDa for the hex-
amer. None of these results was concentration dependent ex-
cept that at pH 7.5 where the enzyme shows polydispersity,
the population of lower oligomers increases as the concentra-
tion decreases. Thus it can be concluded that the transitions
of the oligomeric state in PfFabZ are exclusively pH dependent
and the presence of the substrate or ions bound at the active
site enhances the rate of formation of the active enzyme at high
pH.
The activity of PfFabZ at 7.5 using crotonoyl-CoA gave a
Km of 56 lM and Kcat value of 0.078 s
1. Activity assay
showed that the enzyme lost 90% activity at pH 4.5 and re-
gained around 50% activity by increasing the pH.
3.6. Structural basis for the oligomeric shift
It is apparent from our studies, both crystallographic and
solution, that a pH change triggers transition between inactive
dimers of PfFabZ and active hexamers. In the hexameric form
of the enzyme, all the active site loops are stabilized by inter-
actions at the dimer–dimer interface which compensate for the
energetically less favourable cis peptide bonds. The catalytic
residues Glu147 and His133 are appropriately positioned to
interact with the substrate. His98 along with His133 and
Glu147 was found to interact with the cacodylate ion in
h-PfFabZ suggesting that it has a signiﬁcant role to play in
substrate binding. As the pH decreases, these two histidine res-
idues acquire more positive charge leading to an electrostatic
repulsion between them resulting in both of them getting ex-
pelled from the active site. This is achieved by the ﬂipping
of the side chains of loop A residues in the opposite direction
and a backward movement of loop B caused by a cis–trans
peptide ﬂip at His133-Phe134. In their new positions His133
of one subunit and Phe134 from the subunit involved in hex-
amer contacts introduce a steric clash with the cis peptide of
loop A, i.e., Tyr100-Pro101. As a result, this cis peptide is also
converted to trans moving loop A into the active site tunnel
with Arg99 side chain protruding into the active site. Loop
A again pushes the N-terminus of the b-strand at the dimeric
interface 3 A˚ away from the tunnel along with Phe169. The
catalytic residue Glu147 might also be indirectly responsible
for the electrostatic repulsion as it gets more protonated and
less negative at low pH thus reducing its contribution to
charge compensation. As a consequence of all the structural
changes, the dimer–dimer interface is disrupted creating inac-
tive dimers as they lack proper active site geometry to interact
with the substrate. In the reverse reaction, as pH increases, the
active hexameric form is achieved when the histidine residues
return to their positions to perform enzymatic reaction by two
trans–cis peptide ﬂips and the dimers come together with
favourable interactions between them to form a hexamer.
The argument that the structural changes are triggered by
charge repulsion was strengthened by the non-conversion of
the hexameric His98Ala mutant of PfFabZ to dimers at low
pH as observed by DLS experiments (Sharma et al., to be
published).4. Conclusions
The dimeric nature and a novel architecture of the catalytic
site of d-PfFabZ make it distinctly diﬀerent from the hexa-meric form of the enzyme. By a combination of crystal struc-
ture analysis, DLS and chromatography we could clearly
demarcate the conditions in which each of these forms exists.
The present work for the ﬁrst time indicates the possibility
of regulation of the activity of FabZ from any source by the
change in its oligomerization. This study showing the pH-
dependent functioning of PfFabZ should help in the design
of more eﬃcient inhibitors of the enzyme especially directed
to stabilize its inactive dimeric state and thereby aid in an eﬀort
to combat malaria.
Coordinates and the structure factors have been deposited in
the Protein Data Bank (PDB code: 1ZHG).
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